Table 1.
Baseline Characteristics of Patients With Central Serous Chorioretinopathy
| Characteristics | Observed Controls (N = 15) | Treated Patients (N = 18) | P Value |
|---|---|---|---|
| Age, y (±SD) | 51.3 (±12.7) | 47.0 (±13.4) | 0.39 |
| Male, % | 87 | 72 | 0.31 |
| Right eyes, % | 53 | 44 | 0.99 |
| FFA/ICGA confirmed | 87% | 89% | 0.90 |
| Mean duration of CSCR prior to enrollment, months (range) | 8.8 (3–24) | 5.8 (3–24) | 0.19 |
| Initial BCVA, mean (±SD) | 77.9 (±11.3) | 78.5 (±13.4) | 0.91 |
| Initial CMT, mean µm (SD) | 370.5 (±97.4) | 427.8 (±107.4) | 0.07 |
| Initial IOP, mm Hg (SD) | 16.8 (±2.1) | 16.7 (±1.9) | 0.88 |
| Initial choroidal thickness, mean µm (SD) | 404.0 (±97.4) | 437.5 (±88.3) | 0.37 |
BCVA, best corrected visual acuity; CMT, central macular thickness; CSCR, central serous chorioretinopathy; FFA, fundus fluorescein angiography; ICGA, indocyanine green angiography; IOP, intraocular pressure; SD, standard deviation.